Chemical Compound Review:
Plitican 6-methoxy-N-[(1-prop-2- enylpyrrolidin-2...
Synonyms:
Limican, Litican, Liticum, Superan, Vergentan, ...
- The antiemetic activity of high-dose alizapride and high-dose metoclopramide in patients receiving cancer chemotherapy: a prospective, randomized, double-blind trial. Joss, R.A., Galeazzi, R.L., Bischoff, A.K., Pirovino, M., Ryssel, H.J., Brunner, K.W. Clin. Pharmacol. Ther. (1986)
- Antiemetic efficacy of escalating doses of alizapride against chemotherapy-induced emesis. Abad-Esteve, A., Rosell, R., Moreno, I., Serichol, M., Moya, L., Ribas-Mundo, M. Oncology (1989)
- Effect of intravenous alizapride on spinal morphine-induced pruritus. Horta, M.L., Vianna, P.T. British journal of anaesthesia. (2003)
- High-dose alizapride versus high-dose domperidone: a double-blind comparative study in the management of cis-platinum-induced emesis. Huys, J., Troch, M., Bourguignon, R.P., Smets, P. Current medical research and opinion. (1985)
- Alizapride in the prevention of postoperative vomiting. A double-blind comparison. Vanacker, B., Van Aken, H. Acta anaesthesiologica Belgica. (1988)
- Does dexamethasone enhance the efficacy of alizapride in cis-platinum-induced delayed vomiting and nausea? Münstedt, K., Wunderlich, I., Blauth-Eckmeyer, E., Zygmunt, M., Vahrson, H. Oncology (1998)
- Oral ondansetron in the prevention of chemotherapy-induced emesis in breast cancer patients. French Ondansetron Study Group. Clavel, M., Bonneterre, J., d'Allens, H., Paillarse, J.M. Eur. J. Cancer (1995)
- A comparison of ondansetron with alizapride plus methylprednisolone in the control of cisplatin-induced emesis. The French Pneumology Group for the Ondansetron Study. Depierre, A., Lebeau, B., d'Allens, H. Oncology (1992)
- The antiemetic activity of high-dose metoclopramide and high-dose alizapride in combination with lorazepam in patients receiving cancer chemotherapy. A prospective, randomized, double-blind study. Molino, A., Guglielmo, L., Azzolini, M.E., Biondani, P., Capelli, M.C., Grandinetti, A., Griso, C., Martinelli, G., Martini, N., Zanotti, R. Oncology (1991)
- High doses of methylprednisolone with or without alizapride in the prevention of cisplatin-induced emesis. A randomized, double-blind, crossover study. Giaccone, G., Bertetto, O., Secat, M.A., Calciati, A. Oncology (1988)
- Tropisetron. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential as an antiemetic. Lee, C.R., Plosker, G.L., McTavish, D. Drugs (1993)
- Study of the prophylactic effect of droperidol, alizapride, propofol and promethazine on spinal morphine-induced pruritus. Horta, M.L., Morejon, L.C., da Cruz, A.W., Dos Santos, G.R., Welling, L.C., Terhorst, L., Costa, R.C., Alam, R.U. British journal of anaesthesia. (2006)
- Activity of a new antiemetic agent: alizapride. A randomized double-blind crossover controlled trial. Bleiberg, H., Gerard, B., Dalesio, O., Crespeigne, N., Rozencweig, M. Cancer Chemother. Pharmacol. (1988)
- Absolute intramuscular, oral, and rectal bioavailability of alizapride. Houin, G., Barre, J., Tillement, J.P. Journal of pharmaceutical sciences. (1984)
- Pharmacokinetics of alizapride in children receiving chemotherapy for solid tumour. Rey, E., Stettler, E., D'athis, P., Pons, G. Fundamental & clinical pharmacology. (2001)
- Manometric study of the activity of alizapride on the motor function of the human sphincter of Oddi. Warzee, P.L., Dive, C.C. Journal of clinical pharmacy and therapeutics. (1988)
- Anti-emetic effect of high-dose metoclopramide vs alizapride--a randomised crossover study. Seng, K.T., Tiong, C.E., Hiang, T.C. British journal of clinical pharmacology. (1994)
- Comparison of the in-vitro receptor selectivity of substituted benzamide drugs for brain neurotransmitter receptors. Chivers, J.K., Gommeren, W., Leysen, J.E., Jenner, P., Marsden, C.D. J. Pharm. Pharmacol. (1988)
- Quantitative determination of alizapride in human plasma by high-performance liquid chromatography. Coulais, Y., Campistron, G., Caillard, C., Houin, G. J. Chromatogr. (1986)